Correlation Between Azul SA and OnKure Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Azul SA and OnKure Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Azul SA and OnKure Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Azul SA and OnKure Therapeutics,, you can compare the effects of market volatilities on Azul SA and OnKure Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Azul SA with a short position of OnKure Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Azul SA and OnKure Therapeutics,.

Diversification Opportunities for Azul SA and OnKure Therapeutics,

0.92

Correlation Coefficient

Azul SA  OnKure Therapeutics,

Almost no diversification

The 3 months correlation between Azul and OnKure is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Azul SA and OnKure Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OnKure Therapeutics, and Azul SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Azul SA are associated (or correlated) with OnKure Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OnKure Therapeutics, has no effect on the direction of Azul SA i.e., Azul SA and OnKure Therapeutics, go up and down completely randomly.

Pair Corralation between Azul SA and OnKure Therapeutics,

Given the investment horizon of 90 days Azul SA is expected to under-perform the OnKure Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Azul SA is 1.17 times less risky than OnKure Therapeutics,. The stock trades about -0.03 of its potential returns per unit of risk. The OnKure Therapeutics, is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  2,600  in OnKure Therapeutics, on October 4, 2024 and sell it today you would lose (1,748) from holding OnKure Therapeutics, or give up 67.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Azul SA  vs.  OnKure Therapeutics,

Azul SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Azul SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

OnKure Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OnKure Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Azul SA and OnKure Therapeutics,

The main advantage of trading using opposite Azul SA and OnKure Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Azul SA position performs unexpectedly, OnKure Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will offset losses from the drop in OnKure Therapeutics,'s long position.

The idea behind Azul SA and OnKure Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.